Protalix BioTherapeutics

Protalix BioTherapeutics

PLX· Manufacturing· Fiscal year ends in December

CEO pay in FY2025

Dror Bashan is the CEO of Protalix BioTherapeutics and was paid $1.2M in FY2025 (Dec), down 24%.

PayNo stock prices for these years
CEO pay is from each Protalix BioTherapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Dror BashanFY2025
  2. 2Eyal RubinFY2025
  3. 3Yaron NaosFY2025
  4. 4Gilad MamlokFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Protalix BioTherapeutics paid its 4 named executives $3.0M in total in FY2025 (Dec). CEO Dror Bashan was paid $1.2M of that.

Name
Dror BashanPresident and Chief Executive Officer
Eyal RubinSenior Vice President and Chief Financial Officer
Yaron NaosSenior Vice President, Chief Operating Officer
Gilad MamlokSenior Vice President and Chief Financial OfficerNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Protalix BioTherapeutics. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings6

See all
Proxy statementDEF 14AApr 30, 2026FY2025
Annual report10-KMar 18, 2026FY2025
Proxy statementDEF 14AApr 30, 2025FY2024
Annual report10-KMar 17, 2025FY2024
Proxy statementDEF 14AApr 29, 2024FY2023
Annual report10-KMar 14, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data